Platelet Rich Plasma Shows Promise for Chronic Lower Back Pain Relief
Military study tests regenerative PRP injections against placebo for facet joint pain in 91 participants.
Summary
Researchers at Womack Army Medical Center completed a study testing whether platelet-rich plasma (PRP) injections can effectively treat chronic lower back pain caused by facet joint problems. The trial enrolled 91 military personnel who received either PRP or placebo injections directly into their lumbar facet joints. Lower back pain is the leading cause of disability and medical visits among military personnel, costing the healthcare system $88 billion annually. PRP therapy uses concentrated platelets from the patient's own blood to potentially stimulate healing and reduce inflammation without damaging joint structures, unlike some traditional treatments that create destructive lesions.
Detailed Summary
A completed clinical trial at Womack Army Medical Center investigated whether platelet-rich plasma (PRP) injections can effectively treat chronic lower back pain caused by facet joint dysfunction. The study addressed a critical military health issue, as lower back pain represents the single most common cause of disability and primary care visits among service members.
The randomized, placebo-controlled trial enrolled 91 military personnel with confirmed facet joint-mediated lumbar pain. Participants received either point-of-care generated PRP or placebo injections directly into affected lumbar facet joints. The study ran from September 2021 through June 2025, allowing researchers to track both immediate and long-term outcomes.
PRP therapy represents a regenerative medicine approach that concentrates healing factors from patients' own blood. Unlike traditional treatments like radiofrequency ablation that create destructive lesions, PRP aims to preserve and potentially restore facet joint structures while reducing pain and improving function. This preservation-focused approach could enhance patients' ability to participate in rehabilitation therapy.
The trial specifically measured pain reduction, functional improvement, and return-to-duty status among participants. With lower back and neck pain accounting for approximately $88 billion in annual healthcare expenditures, effective treatments could significantly impact both individual quality of life and healthcare costs.
While detailed results await publication, this study provides crucial evidence-based data on regenerative medicine approaches for spinal pain management. The findings could influence treatment protocols not only for military personnel but also for civilian populations suffering from similar facet joint-related back pain, potentially offering a less invasive alternative to conventional interventions.
Key Findings
- First randomized controlled trial testing PRP versus placebo for lumbar facet joint pain
- Study completed enrollment of 91 military personnel with chronic lower back pain
- PRP therapy aims to preserve joint structures unlike destructive conventional treatments
- Lower back pain costs healthcare system $88 billion annually in direct and indirect expenses
Methodology
Randomized, placebo-controlled trial enrolling 91 military participants over approximately 4 years. Point-of-care PRP generation compared against placebo injections into lumbar facet joints. Study design allows assessment of both short and long-term treatment outcomes.
Study Limitations
Study limited to military population which may not represent general civilian demographics. Results not yet published, preventing assessment of treatment efficacy. Single-center design may limit generalizability of findings.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.